Category Archives: Biotechnology

Biotechnology Certificate Program at Bethel College The bioscience industry is one of the fastest growing fields in America, with projected job growth of 10% by 2022. You can join this exciting industry with Bethel's Biotechnology Certificate... By: BethelCollegeIndiana … Continue reading →

Government holds National Biotechnology Week The government will hold a National Biotechnology Week, in recognition of the said field's contribution to the country's economy, specially in agriculture. Visit our website at: http://www.eaglene... By: EagleNews PH … Continue reading →

Photo courtesy of CHEd MANILA, PhilippinesTo enable Filipinos to better understand and appreciate the use of biotechnology, different government agencies have set a series of activities for this years celebration of Biotechnology Week. With the theme, Edukasyon sa Bioteknolohiya: Pagyamanin para sa Kinabukasan Natin (Fostering Education in Biotechnology for our Future), the Commission on Higher Education (CHEd) will host this years celebration which will run from Nov. 24 to 28. Participating agencies include the departments of Science and Technology, Agriculture, Environment and Natural Resources, Education, Health, Trade and Industry, and Interior and Local Government. Biotechnology is the use of living organisms or biological systems to develop, make or modify products with specific uses and is particularly applied in the areas of medicine, agriculture, industry and the environment. The activities for Biotechnology Week will kick off Monday at the CHEd office in Diliman, Quezon City, where the latest applications of biotechnology in health, food security and the environment will be featured. Under Presidential Proclamation No. 1414, the last week of November has been declared Biotechnology Week in keeping with the governments policy to promote safe and responsible use of modern biotechnology and its products as one of several means to achieve … Continue reading →

Biotechnology + Career at Stevenson University Stevenson University, known for its distinctive career focus, is the third-largest independent undergraduate university in Maryland with more than 4400 stud... By: Stevenson University … Continue reading →

Puma Biotechnology, Inc. 's ( PBYI ) shares lost 9.7% immediately after the company announced the top-line results from a randomized, two-arm, phase II study (NEfERTT) on its lead candidate, neratinib. Neratinib, in combination with paclitaxel, failed to show significant improvement in progression free survival (PFS) in patients suffering from first-line HER2-positive locally recurrent or metastatic breast cancer when compared to paclitaxel plus Roche's ( RHHBY ) Herceptin. The primary endpoint of the NEfERTT study was PFS. In this study, patients were randomized to receive first-line treatment with paclitaxel plus neratinib or paclitaxel plus Herceptin. Results showed that patients treated with paclitaxel plus neratinib achieved a PFS of 16.6 months while patients receiving paclitaxel plus Herceptin achieved a PFS of 16.7 months. However, the company stated that the incidence of central nervous system metastases in the patients treated with paclitaxel-neratinib combination was reduced by 52.6% than those treated with paclitaxel plus Herceptin. Detailed data from the NEfERTT study will be available in 2015. We note that Puma Biotechnology has a licensing agreement with Pfizer ( PFE ) for neratinib. Our Take We are disappointed by the top-line results from the NEfERTT study. Neratinib being the primary candidate at Puma Biotechnology, … Continue reading →

The Surrey-based developer of stem cell therapies has attracted investment from the likes of top fund manager Neil Woodford who has a 20 per cent stake, and is poised to move from Surrey into purpose-built laboratories in Wales early next year. Loading article content It said last year's loss was as expected at 4.13m after the previous year's 3.17m, while cash had eroded from 20.9m in March to 16.1m at September 30. ReNeuron conducted a groundbreaking patient trial for its stroke disability therapy at Glasgow's Southern General Hospital in 2012-13, conducted by a team from Glasgow University led by Professor Keith Muir. It reported that some patients regained movement in their limbs and showed "modest" improvements in condition, despite all having had their strokes between six months and five years earlier. Its success triggered a major investment into the group by biotechnology guru Sir Chris Evans, who joined the board in August last year. This year ReNeuron began a Phase 1 safety study at Ninewells Hospital in Dundee of its therapy for people with lower limb ischaemia, which can lead to limb amputation. The group yesterday cited "encouraging long term Phase 1 data" from the stroke study and said Phase … Continue reading →

Diana Ostos, Biotechnology Master at D-BSSE, ETH Zurich Learn more about the Biotechnology study programme of ETH Zurich at the Department of Biosystems Science and Engineering in Basel (D-BSSE). Diana talks about... By: ETH Zrich … Continue reading →

Man-on-the-street interview (Biotechnology) At Biodidact, one of our goals is to get our communities involved in science discussions. This video is the first of a series of man-on-the-street interviews. Each month, we plan on bringing... By: Biodidact, The Community Lab … Continue reading →

Manuel Mohr, Biotechnology Master at D-BSSE, ETH Zurich Learn more about the Biotechnology study programme of ETH Zurich at the Department of Biosystems Science and Engineering in Basel (D-BSSE). Manuel provides i... By: ETH Zrich … Continue reading →

Suman Kumar (biotechnology)central uiversity of rajasthan. Plant Growth Promting Rhizobacteria.Hpw to isolate the rhizobacteria...this sample colection of the Churu Rajasthan India. and extraction the Soil.....and th... By: suman kumar … Continue reading →